Novartis, Roxane Drop Most Famvir Patent Claims

Law360, New York (January 6, 2010, 2:58 PM EST) -- A federal judge has approved a joint move by Novartis Pharmaceuticals Corp. and Roxane Laboratories Inc. to dismiss claims regarding three of four patents in the drugmakers' battle over Novartis herpes treatment Famvir.

Judge Jose L. Linares of the U.S. District Court for the District of New Jersey on Tuesday signed off on the consent order for the joint stipulation of dismissal with prejudice by the companies, which agreed to drop claims and counterclaims against each other in the consolidated case, but left alive claims concerning...
To view the full article, register now.